High-resolution aberrometry

Article

Even without refned nomograms, new-generation aberrometry is contributing to better results

We have consistently found that uncorrected distance vision is the best predictor of patient satisfaction after laser vision correction. Moreover, every line of visual acuity, even beyond the 'ideal' of 20/20, results in greater patient satisfaction with the procedure and a greater likelihood of positive referrals.

Optical Express centres in the UK have been evaluating the efficacy of a new high-resolution aberrometer (iDesign, Abbott Medical Optics, Santa Ana, California, USA) for wavefront-guided laser vision correction.

Study design and results

The performance of the new aberrometer was evaluated in 675 eyes of 348 patients undergoing refractive surgery between May and October 2012. These patients presented with a wide range of preoperative refractive error. Preoperative sphere ranged from –9.50 D to +4.25 D (mean: –1.86 ± 2.42 D) and preoperative cylinder was as much as 5.50 D in some eyes (mean: –0.76 ± 0.83 D).

At one month, 90% of all eyes had a manifest spherical equivalent (MSE) within 0.50 D of intended correction and 97% were within 1.00 D. The linear regression for attempted versus achieved MSE was 1.01, with a very strong correlation coefficient (0.97). Monocular uncorrected visual acuity (UCVA) was 20/25 or better in 93% of eyes and 20/16 or better in more than 70% of eyes.

Most impressive were the astigmatism correction results. One month postoperatively, the mean cylinder had been reduced to –0.18 ± 0.25 D, and 95% of the eyes had visually insignificant (less than 0.5 D) of cylinder. This is the best cylinder correction I have ever seen following an excimer laser procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.